BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hatchtech 

205 - 211 Grattan Street
P.O. Box 4192
Parkville  Victoria  3052  Australia
Phone: 61-3-8344-3190 Fax: 61-3-9347-5888


SEARCH JOBS




Industry
Biotechnology






 Company News
Hatchtech Completes $12.6 Million Capital Raise, Secures Funds for Phase III Trial and NDA Submission, and Announces Board Changes 10/31/2013 7:19:50 AM
Hatchtech Appoints New CEO and Completes Financing Round 5/1/2012 6:43:01 AM
Hatchtech Extends Patent Protection for DeOvo™ Head Lice Treatment 2/15/2012 10:31:05 AM
Successful Completion of Hatchtech’s Phase 2b Clinical Trial in Head Lice 12/15/2011 6:31:58 AM
Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo(TM) 9/1/2011 6:12:20 AM
Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment DeOvoT 8/31/2011 10:38:51 AM
Hatchtech Commences 2b Clinical Trial of New-Generation Head Lice Treatment DeOvo(TM) 5/2/2011 7:38:31 AM
Hatchtech Board and Management Changes; Hatchtech Today Announced that Paul MacLeman Has Resigned as CEO 4/21/2009 8:35:20 AM
Hatchtech to Go to Phase II Trial 1/21/2008 7:58:48 AM